Literature DB >> 10065623

IgE and tumor necrosis factor in malaria infection.

P Perlmann1, H Perlmann, G ElGhazali, M T Blomberg.   

Abstract

IgE, the immunoglobulin instrumental in atopic diseases is also elevated in many infections. This paper reports on the occurrence and possible pathogenic role of IgE in human Plasmodium falciparum malaria, one of the most widely spread and severe infectious diseases world wide. Plasmodial infections induce IgE elevation in the blood of the majority of people living in malaria endemic areas and up to 5% of this IgE constitutes anti-malaria antibodies. Production of IgE is controlled by T cells and elevated IgE concentrations in the blood of malaria patients are the result of an increased ratio of T-helper 2 (Th2) over T-helper 1 (Th1) cells. The underlying Th1 to Th2 switch is controlled by a variety of environmental and genetic factors. The importance of the latter is demonstrated by the IgE levels occurring in monozygotic or dizygotic twins originating from malarious areas of Africa. While these levels were indistinguishable within monozygotic twin pairs, they were different within the dizygotic pairs. Comparison of the levels of total IgE or IgE anti-malaria antibodies in patients with uncomplicated malaria with those in patients with the severe form of the disease (cerebral malaria or severe malaria without cerebral involvement) indicate that these levels are significantly higher in the cases with severe disease. This is the reverse with IgG and suggests that IgE plays a role in malaria pathogenesis. An important pathogenic mediator causing malaria fever and tissue lesions is tumor necrosis factor (TNF), generally believed to be induced by toxins released from the parasite. However, sera from malaria patients can also cause TNF release from monocytes in a reaction dependent on the presence of IgE containing immune complexes or aggregates. This results in induction and cross-linking of Fcepsilon receptor II (CD23) and by binding to and activating these cells, IgE will contribute to a local over-production of TNF in capillaries and post-capillary venules where P. falciparum parasites or their products accumulate in the severe forms of this disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10065623     DOI: 10.1016/s0165-2478(98)00120-5

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  25 in total

Review 1.  Cytokines in the pathogenesis of and protection against malaria.

Authors:  Iñigo Angulo; Manuel Fresno
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

2.  Genotype combinations of two IL4 polymorphisms influencing IL-4 plasma levels are associated with different risks of severe malaria in the Malian population.

Authors:  Sandrine Cabantous; Stéphane Ranque; Belco Poudiougou; Abdoulaye Traore; Sofiane Berbache; Joana Vitte; Pierre Bongrand; Ogobara Doumbo; Alain J Dessein; Laurent Abel; Sandrine Marquet
Journal:  Immunogenetics       Date:  2015-05-03       Impact factor: 2.846

3.  Genetic vaccination against malaria infection by intradermal and epidermal injections of a plasmid containing the gene encoding the Plasmodium berghei circumsporozoite protein.

Authors:  R Weiss; W W Leitner; S Scheiblhofer; D Chen; A Bernhaupt; S Mostböck; J Thalhamer; J A Lyon
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria.

Authors:  E Ayimba; J Hegewald; A Y Ségbéna; R G Gantin; C J Lechner; A Agosssou; M Banla; P T Soboslay
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

5.  Pro- and anti-inflammatory cytokines in children with malaria in Franceville, Gabon.

Authors:  Sandrine Lydie Oyegue-Liabagui; Aline Gaëlle Bouopda-Tuedom; Lady Charlène Kouna; Sydney Maghendji-Nzondo; Herman Nzoughe; Nina Tchitoula-Makaya; Irene Pegha-Moukandja; Jean-Bernard Lekana-Douki
Journal:  Am J Clin Exp Immunol       Date:  2017-02-15

6.  Life history, immune function, and intestinal helminths: Trade-offs among immunoglobulin E, C-reactive protein, and growth in an Amazonian population.

Authors:  Aaron D Blackwell; J Josh Snodgrass; Felicia C Madimenos; Lawrence S Sugiyama
Journal:  Am J Hum Biol       Date:  2010 Nov-Dec       Impact factor: 1.937

7.  Impact of mosquito bites on asexual parasite density and gametocyte prevalence in asymptomatic chronic Plasmodium falciparum infections and correlation with IgE and IgG titers.

Authors:  Ramatoulaye Lawaly; Lassana Konate; Laurence Marrama; Ibrahima Dia; Diawo Diallo; Fatoumata Diène Sarr; Bradley S Schneider; Isabelle Casademont; Mawlouth Diallo; Paul T Brey; Anavaj Sakuntabhai; Salah Mecheri; Richard Paul
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

8.  Antibody responses to a C-terminal fragment of the Plasmodium falciparum blood-stage antigen Pf332 in Senegalese individuals naturally primed to the parasite.

Authors:  E Israelsson; H Balogun; N-M Vasconcelos; J Beser; C Roussilhon; C Rogier; J F Trape; K Berzins
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

9.  Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children.

Authors:  B A Gyan; B Goka; J T Cvetkovic; J L Kurtzhals; V Adabayeri; H Perlmann; A-K Lefvert; B D Akanmori; M Troye-Blomberg
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

10.  Humoral responses against the C-terminal region of merozoite surface protein 1 can be remembered for more than 30 years in persons exposed to Plasmodium vivax.

Authors:  Kook Jin Lim; Jea Won Park; Joon-Sup Yeom; Young-Ha Lee; Seung Bum Yoo; Jae Hoon Oh; Mi Jin Sohn; Young Yil Bahk; Yu Sam Kim
Journal:  Parasitol Res       Date:  2004-01-27       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.